Search Results | Cancer Research | American Association for Cancer Research

1-20 of 23

Sort by

Sort Order Select

Journal Articles

Abstract P6-09-06: BRCAness as a prognostic marker in triple-negative breast cancer patients treated with neoadjuvant chemotherapy: A multicenter retrospective study

Y Kosaka, Y Yamamoto, H Nishimiya, M Ibusuki-Yamamoto, Y Hirota, H Tanino, H Iwase, S Nakamura, S Akashi-Tanaka

Cancer Res (2019) 79 (4_Supplement): P6-09-06.

DOI: https://doi.org/10.1158/1538-7445.SABCS18-P6-09-06

Published: 15 February 2019

View article

Journal Articles

Abstract PD1-03: Single agent activity of U3-1402, a HER3-targeting antibody-drug conjugate, in HER3-overexpressing metastatic breast cancer: Updated results of a phase 1/2 trial

N Masuda, K Yonemori, S Takahashi, T Kogawa, T Nakayama, H Iwase, M Takahashi, T Toyama, T Saeki, S Saji, K Inoue, H Onuma, N Tajima, Y Shiose, S Chen, F Guevara, C Yu, S Ueno, H Iwata

Cancer Res (2019) 79 (4_Supplement): PD1-03.

DOI: https://doi.org/10.1158/1538-7445.SABCS18-PD1-03

Published: 15 February 2019

View article

Journal Articles

Abstract P3-11-02: A randomized phase II trial of toremifene (120 mg) versus fulvestrant (500 mg) after prior non-steroidal aromatase inhibitor in postmenopausal women with hormone receptor-positive metastatic breast cancer (Hi-FAIR fx study)

R Nishimura, Y Yamamoto, K Narui, Y Kijima, Y Hozumi, M Ikeda, S Takao, S Ohtani, H Iwase

Cancer Res (2018) 78 (4_Supplement): P3-11-02.

DOI: https://doi.org/10.1158/1538-7445.SABCS17-P3-11-02

Published: 15 February 2018

View article

Journal Articles

Abstract P1-02-13: Differential expression of exosomal miRNAs between breast cancer patients with recurrence and no-recurrence

A Sueta, Y Yamamoto, M Tomiguchi, T Takeshita, M Ibusuki, H Iwase

Cancer Res (2017) 77 (4_Supplement): P1-02-13.

DOI: https://doi.org/10.1158/1538-7445.SABCS16-P1-02-13

Published: 15 February 2017

View article

Journal Articles

Abstract P1-02-09: Clinical significance of sequential measurements of ESR1 mutations in plasma cell-free DNA in estrogen receptor positive recurrent metastatic breast cancer patients

T Takeshita, Y Yamamoto, M Yamamoto-Ibusuki, A Sueta, M Tomiguchi, H Iwase

Cancer Res (2017) 77 (4_Supplement): P1-02-09.

DOI: https://doi.org/10.1158/1538-7445.SABCS16-P1-02-09

Published: 15 February 2017

View article

Journal Articles

Abstract P6-09-46: A comprehensive analysis of GNAS DNA copy number, levels of mRNA and protein expression in primary breast cancer

M Tomiguchi, Y Yamamoto, M Yamamoto-Ibusuki, L Goto-Yamaguchi, Y Fujiki, A Sueta, T Takeshita, H Iwase

Cancer Res (2017) 77 (4_Supplement): P6-09-46.

DOI: https://doi.org/10.1158/1538-7445.SABCS16-P6-09-46

Published: 15 February 2017

View article

Journal Articles

Abstract P6-09-48: Development of a predictive model by gene expression profiles for pathological CR after neoadjuvant chemotherapy in ER-positive/HER2-negative breast cancer

Y Fujiki, Y Yamamoto, M Yamamoto-Ibusuki, R Goto, M Tomiguchi, A Sueta, T Takeshita, H Iwase

Cancer Res (2017) 77 (4_Supplement): P6-09-48.

DOI: https://doi.org/10.1158/1538-7445.SABCS16-P6-09-48

Published: 15 February 2017

View article

Journal Articles

Abstract P3-05-10: Non-coding RNAs derived from near the ESR1 gene acts as a transcriptional regulator during estrogen deprivation adaptation of ER positive breast cancer cells

S Fujiwara, N Saitoh, S Tomita, MO Abdalla, H Iwase, M Nakao

Cancer Res (2016) 76 (4_Supplement): P3-05-10.

DOI: https://doi.org/10.1158/1538-7445.SABCS15-P3-05-10

Published: 15 February 2016

View article

Journal Articles

Abstract P3-07-11: High activation of PI3K pathway defined by PIK3CA mutation, PTEN, and INPP4B expression are associated with trastuzumab efficacy in HER2-positive breast cancer

A Sueta, Y Yamamoto, T Takeshita, M Yamamoto-Ibusuki, H Iwase

Cancer Res (2016) 76 (4_Supplement): P3-07-11.

DOI: https://doi.org/10.1158/1538-7445.SABCS15-P3-07-11

Published: 15 February 2016

View article

Journal Articles

Abstract P6-07-07: Clinical significance of ESR1 mutations using droplet digital polymerase chain reaction assay in 325 breast cancer samples

T Takeshita, Y Yamamoto, M Yamamoto-Ibusuki, T Inao, A Sueta, S Fujiwara, H Iwase

Cancer Res (2016) 76 (4_Supplement): P6-07-07.

DOI: https://doi.org/10.1158/1538-7445.SABCS15-P6-07-07

Published: 15 February 2016

View article

Journal Articles

Abstract P4-09-01: FGFR1 protein expression is associated with prognosis in primary breast cancer: A comprehensive analysis of gene copy number, mRNA and protein expression

M Tomiguchi, Y Yamamoto, M Yamamoto-Ibusuki, R Yamaguchi, Y Fujiki, S Fujiwara, A Sueta, T Takeshita, T Inao, H Iwase

Cancer Res (2016) 76 (4_Supplement): P4-09-01.

DOI: https://doi.org/10.1158/1538-7445.SABCS15-P4-09-01

Published: 15 February 2016

View article

Journal Articles

Abstract P5-01-13: Poly(I:C), an innate adjuvant receptor ligand, can induce the antitumor effects on human breast cancer cells

T Inao, N Harashima, Y Yamamoto, M Harada, H Iwase

Cancer Res (2013) 73 (24_Supplement): P5-01-13.

DOI: https://doi.org/10.1158/0008-5472.SABCS13-P5-01-13

Published: 15 December 2013

View article

Journal Articles

Abstract P1-14-04: Subsequent endocrine therapy after becoming to resistance of ‘estrogen therapy’ is beneficial as a salvage treatment for the late stage metastatic breast cancer

H Iwase, Y Yamamoto, M Yamamoto-Ibusuki, K-I Murakami, T Inao, Y Okumura, Y Omoto

Cancer Res (2013) 73 (24_Supplement): P1-14-04.

DOI: https://doi.org/10.1158/0008-5472.SABCS13-P1-14-04

Published: 15 December 2013

View article

Journal Articles

Abstract P1-14-01: Randomized controlled trial of toremifene 120 mg compared with exemestane 25 mg after prior non-steroidal aromatase inhibitor treatment in postmenopausal women with hormone receptor-positive metastatic breast cancer (Hi-FAIR ex study)

Y Yamamoto, T Ishikawa, Y Hozumi, M Ikeda, N Kondo, H Yamashita, T Toyama, C Takashi, S Saji, M Yamamoto-Ibusuki, H Iwase

Cancer Res (2013) 73 (24_Supplement): P1-14-01.

DOI: https://doi.org/10.1158/0008-5472.SABCS13-P1-14-01

Published: 15 December 2013

View article

Journal Articles

Abstract P2-14-03: “Ethinylestradiol” is beneficial for postmenopausal advanced breast cancer patients heavily pre-treated with endocrine agents

H Iwase, Y Yamamoto, K-I Murakami, M Yamamoto-Ibusuki, S Tomita, Y Omoto

Cancer Res (2012) 72 (24_Supplement): P2-14-03.

DOI: https://doi.org/10.1158/0008-5472.SABCS12-P2-14-03

Published: 15 December 2012

View article

Journal Articles

Abstract P1-12-01: Evaluation on efficacy and safety of capecitabine plus docetaxel versus docetaxel monotherapy in metastatic breast cancer patients pretreated with anthracycline: Results from a randomized phase III study (JO21095)

N Sato, D Yamamoto, Y Rai, H Iwase, M Saito, H Iwata, N Masuda, S Oura, J Watanabe, K Kuroi

Cancer Res (2012) 72 (24_Supplement): P1-12-01.

DOI: https://doi.org/10.1158/0008-5472.SABCS12-P1-12-01

Published: 15 December 2012

View article

Journal Articles

Abstract P6-05-06: Serum estradiol levels in postmenopausal ER+/PR- breast cancer are lower than those in postmenopausal ER+/PR+

Y Yamamoto, M Ibusuki, H Goto, K Murakami, H Iwase

Cancer Res (2012) 72 (24_Supplement): P6-05-06.

DOI: https://doi.org/10.1158/0008-5472.SABCS12-P6-05-06

Published: 15 December 2012

View article

Journal Articles

P3-03-01: Low Expression of microRNA-210 Is an Independent Good Prognostic Factor in Japanese Triple-Negative Breast Cancer Patients.

T Toyama, N Kondo, Y Endo, H Sugiura, N Yoshimoto, M Iwasa, S Takahashi, H Iwase, Y Fujii, H Yamashita

Cancer Res (2011) 71 (24_Supplement): P3-03-01.

DOI: https://doi.org/10.1158/0008-5472.SABCS11-P3-03-01

Published: 15 December 2011

View article

Journal Articles

P1-09-04: A Genetic Predictor for Breast Cancer Risk in a Japanese Population.

A Sueta, H Ito, H Iwata, S Hosono, M Watanabe, H Iwase, K Tajima, H Tanaka, K Matsuo

Cancer Res (2011) 71 (24_Supplement): P1-09-04.

DOI: https://doi.org/10.1158/0008-5472.SABCS11-P1-09-04

Published: 15 December 2011

View article

Journal Articles

P5-03-02: Aurora A Is Closely Linked to an Aggressive Phenotype of Breast Cancer.

Y Yamamoto, M Ibusuki, K Murakami, H Iwase

Cancer Res (2011) 71 (24_Supplement): P5-03-02.

DOI: https://doi.org/10.1158/0008-5472.SABCS11-P5-03-02

Published: 15 December 2011

View article

NARROW

Abstract P6-09-06: BRCAness as a prognostic marker in triple-negative breast cancer patients treated with neoadjuvant chemotherapy: A multicenter retrospective study

Abstract PD1-03: Single agent activity of U3-1402, a HER3-targeting antibody-drug conjugate, in HER3-overexpressing metastatic breast cancer: Updated results of a phase 1/2 trial

Abstract P3-11-02: A randomized phase II trial of toremifene (120 mg) versus fulvestrant (500 mg) after prior non-steroidal aromatase inhibitor in postmenopausal women with hormone receptor-positive metastatic breast cancer (Hi-FAIR fx study)

Abstract P1-02-13: Differential expression of exosomal miRNAs between breast cancer patients with recurrence and no-recurrence

Abstract P1-02-09: Clinical significance of sequential measurements of ESR1 mutations in plasma cell-free DNA in estrogen receptor positive recurrent metastatic breast cancer patients

Abstract P6-09-46: A comprehensive analysis of GNAS DNA copy number, levels of mRNA and protein expression in primary breast cancer

Abstract P6-09-48: Development of a predictive model by gene expression profiles for pathological CR after neoadjuvant chemotherapy in ER-positive/HER2-negative breast cancer

Abstract P3-05-10: Non-coding RNAs derived from near the ESR1 gene acts as a transcriptional regulator during estrogen deprivation adaptation of ER positive breast cancer cells

Abstract P3-07-11: High activation of PI3K pathway defined by PIK3CA mutation, PTEN, and INPP4B expression are associated with trastuzumab efficacy in HER2-positive breast cancer

Abstract P6-07-07: Clinical significance of ESR1 mutations using droplet digital polymerase chain reaction assay in 325 breast cancer samples

Abstract P4-09-01: FGFR1 protein expression is associated with prognosis in primary breast cancer: A comprehensive analysis of gene copy number, mRNA and protein expression

Abstract P5-01-13: Poly(I:C), an innate adjuvant receptor ligand, can induce the antitumor effects on human breast cancer cells

Abstract P1-14-04: Subsequent endocrine therapy after becoming to resistance of ‘estrogen therapy’ is beneficial as a salvage treatment for the late stage metastatic breast cancer

Abstract P1-14-01: Randomized controlled trial of toremifene 120 mg compared with exemestane 25 mg after prior non-steroidal aromatase inhibitor treatment in postmenopausal women with hormone receptor-positive metastatic breast cancer (Hi-FAIR ex study)

Abstract P2-14-03: “Ethinylestradiol” is beneficial for postmenopausal advanced breast cancer patients heavily pre-treated with endocrine agents

Abstract P1-12-01: Evaluation on efficacy and safety of capecitabine plus docetaxel versus docetaxel monotherapy in metastatic breast cancer patients pretreated with anthracycline: Results from a randomized phase III study (JO21095)

Abstract P6-05-06: Serum estradiol levels in postmenopausal ER+/PR- breast cancer are lower than those in postmenopausal ER+/PR+

P3-03-01: Low Expression of microRNA-210 Is an Independent Good Prognostic Factor in Japanese Triple-Negative Breast Cancer Patients.

P1-09-04: A Genetic Predictor for Breast Cancer Risk in a Japanese Population.

P5-03-02: Aurora A Is Closely Linked to an Aggressive Phenotype of Breast Cancer.

Email alerts

AACR Journals

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only